pillbase.ru

Dectova

Active substance: zanamivir

zanamivir

Centralised EU authorisationActive

Marketing holder: GlaxoSmithKline Trading Services Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Реленза
    порошок для ингаляций дозированный, 5 мг/доза, 20 мг (4 дозы) (original in Russian, GRLS)
    ЛП-№(006063)-(РГ-RU)
    АО "ГлаксоСмитКляйн Трейдинг"
  • Реленза
    порошок для ингаляций дозированный, 5 мг/доза, 20 мг (4 дозы) (original in Russian, GRLS)
    ЛСР-000095
    АО "ГлаксоСмитКляйн Трейдинг"
US 2
  • RELENZA
    POWDER · ZANAMIVIR 5 mg/1
    50090-8016
    A-S Medication Solutions
  • RELENZA
    POWDER · ZANAMIVIR 5 mg/1
    0173-0681
    GlaxoSmithKline LLC
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-75d0-7712-92a4-b28870f7f659,01a120c4-0a18-7dda-baea-4699f4646505;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-5e3f-7c12-935e-6440722a3afa,01a1209a-ec00-7a6c-b3d0-dad64dc0a206;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004102
Registration status
Active
ATC code
J05AH01
Sources
  • product · EMA · EMEA/H/C/004102 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004102 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004102 · Verified 2026-10-09